HomeNSB • ASX
add
Neuroscientific Biopharmaceuticals Ltd
Previous close
$0.093
Day range
$0.086 - $0.090
Year range
$0.034 - $0.26
Market cap
30.24M AUD
Avg Volume
175.82K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 158.95K | — |
Operating expense | 1.04M | 353.66% |
Net income | -849.71K | -362.36% |
Net profit margin | -534.56 | — |
Earnings per share | — | — |
EBITDA | -597.26K | -188.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.36M | 41.48% |
Total assets | 16.66M | 232.64% |
Total liabilities | 207.86K | 699.36% |
Total equity | 16.45M | — |
Shares outstanding | 332.58M | — |
Price to book | 1.86 | — |
Return on assets | -13.63% | — |
Return on capital | -13.81% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -849.71K | -362.36% |
Cash from operations | -454.20K | -97.14% |
Cash from investing | -2.62M | — |
Cash from financing | — | — |
Net change in cash | -3.08M | -1,236.52% |
Free cash flow | -158.67K | -30.24% |
About
Founded
2002
Website
